2019 CYIR Finalized
SECTION MODERATORS Victor E. Ortega, MD, PhD, ATSF Wake Forest School of Medicine Department of Pulmonary, Critical Care, Allergy, and Immunologic Medicine Winston-Salem, NC Joyce S. Lee, MD University of Colorado Denver Division of Pulmonary Sciences & Critical Care Medicine Aurora, CO Patricia A. Kritek, MD, EdM Department of Medicine Division of Pulmonary, Critical Care and Sleep Medicine University of Washington School of Medicine Seattle, WA TABLE OF CONTENTS A1 Sunday, May 19 Sepsis and Septic Shock . ................................................................. 3 Health Disparities ............................................................................... 8 COPD ............................................................................................... 12 Interventional Pulmonology ............................................................. 15 B1 Monday, May 20 Sarcoidosis ...................................................................................... 19 Mycobacterial Infections .................................................................. 22 Asthma ............................................................................................. 27 ARDS ............................................................................................... 31 This session and the International Conference are supported by educational grants from Genentech, Inc., Insmed Incorporated, Mallinckrodt Pharmaceuticals, Novartis Pharmaceuticals Corporation, Sanofi Genzyme and Regeneron Pharmaceuticals. All CME sessions have been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) and are free of the control of commercial interests. C1 Tuesday, May 21 General Critical Care . ...................................................................... 34 ICU Rehabilitation ............................................................................ 40 ILD .................................................................................................... 43 Tobacco Dependence ...................................................................... 47 This session and the International Conference are supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., Genentech, Inc. All CME sessions have been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) and are free of the control of commercial interests. D1 Wednesday, May 22 Lung Cancer .................................................................................... 51 Palliative Medicine ........................................................................... 54 Update on Pulmonary Vasular Disease ........................................... 58 Medical Education ........................................................................... 62 This session and the International Conference are supported by educational grants from AstraZeneca LP, Bayer US. All CME sessions have been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) and are free of the control of commercial interests.
Made with FlippingBook
RkJQdWJsaXNoZXIy MTM1ODMw